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CLINICAL APPLICATION OF A TEST FOR LUPUS GLOBULIN-NUCLEOHISTONE
INTERACTION USING FLUORESCENT ANTIBODY**
In studies reported elsewhere we have demonstrated by the fluorescent
antibody technique that serum of patients with disseminated lupus erythe-
matosus contains a globulin factor with a marked affinity for nuclei.7'8 In
further investigation of this reaction it was shown that the component of
nuclei involved was in the nucleoprotein fraction." During this study a
method for titration of this activity of sera was developed which utilized
a nucleoprotein extract of calf thymus. With this method it-was possible
to obtain reproducible titration of activity of sera in a more refined system
than that involving intact nuclei. A preliminary study indicated that an
extensive survey of the occurrence of this factor in human sera would be
of interest.' These results are the subject of the present report.
MATERIALS AND METHODS
Fluorescent anttibody techniqiue. Complete details of this technique have been.reported
elsewhere and will therefore not be described here."8 The method utilizes a fluorescent
dye, chemically bound to antibody, as a visual tracer or stain of a specific antigen. An
indirect procedure was employed in application of the technique to this problem. Nucleo-
protein was first exposed to the serum being tested, and after excess serum was washed
away, to fluorescent rabbit antibody for human gamma globulin. The preparations were
then examined under the microscope with a powerful source of ultra-violet light. When
fluorescence was observed, it indicated that human gamma globulin from the serum
being tested was bound to the insoluble nucleoprotein.
Nutcleoprotein. Calf thymus nucleohistone was prepared by the method of Crampton,
Lipschutz, and Chargaff.' After preparation it was dissolved in distilled water adjusted
to pH 7.0 by addition of NaHCO3 to approximately .0004 M. This material was divided
into aliquots sufficient for several days' work and frozen at -60' C. When prepared
and stored in this way the material remained useable for several months, after which
noticeable deterioration had occurred. As needed for testing a small quantity was
thawed and mixed with an equal volume of 2 M NaCl, forming a clear viscous solution.
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Drops of about .05 ml. volume were placed on glass slides and fanned until dry or,
during humid weather, placed in enclosed trays over Drierite. Nucleoprotein spots
prepared from this concentrated salt solution were found to be the most satisfactory
preparations for this work. The homogeneous character of the solution facilitated
handling, and the crystalline pattern resulting from drying of the salt gave contrast
which aided in evaluation of fluorescent staining. When thoroughly dry, slides were
dipped in 0.15 M NaCl to remove excess salt. After draining, excess moisture was
blotted from the edges of the slide. Processing with serum and fluorescent antibody was
then carried out.
HUMAN SERA
Sera from 369 individuals were tested for their affinity for nucleohistone spots. Most
of the sera were from patients at the Grace-New Haven Community Hospital, New
Haven, and the Veterans Adnministration Hospital, West Haven, Connecticut. A few
specimens were obtained elsewhere. Sera were frozn at -20° C. from the time
received in the laboratory until tested. Results of tests with intact nuclei using some of
these sera were the subject of an earlier report.8
The categories of patients tested are indicated in Table 1. In collecting the sera an
attempt was made to include certain groups which seemed particularly important for
purposes of comparison. In addition, large numbers of sera from miscellaneous unrelated
diseases have been included.
The patients with disseminated lupus had been diagnosed by the usual criteria. In
each case there was agreement on the diagnosis by several competent observers. The
L.E. test had been positive sometime during the course of the disease in all except three
of these patients. The diagnoses recorded were established without knowledge of
results of the tests with fluorescent antibody.
Flutorescent antibody test procedutre. Nucleohistone spots, prepared as described
above, were flooded with the serum specimen being tested and placed for 30 minutes in
a moist chamber at room temperature. After this they were washed twice for five
minutes each with buffered saline. They were then flooded with fluorescent conjugate at
a 1: 5 dilution for 30 minutes, washed again as above, drained and mounted in buffered
glycerol under a cover slip. Slides were examined under the microscope with the
filtered high intensity ultra-violet light source described elsewhere.
The diluent for all serum dilutions and washings in the steps outlined above was
isotonic phosphate buffered saline at pH 7.0. Tests were done first with undiluted serum
and at 1: 16 dilution, followed by twofold serial dilutions over the range appropriate
for determining the end point. To minimize bias during reading, the sequence of the
dilutions was mixed in a manner unknown to the person reading the tests. Results were
recorded as negative when green fluorescence was not observed, plus-minus (uncertain),
and one plus to four plus, depending on the brightness of fluorescent staining. The
highest dilution giving at least a one plus reaction was considered the titer of that
particular serum. Certain sera gave weak and variable reactions (plus minus-one plus)
when tested undiluted, and therefore only sera causing fluorescence at 1: 2 or higher
have been tabulated in final analysis of results. Except for the variable weak reactions
in some tests with undiluted sera, results of repeated tests at different times on individual
serum specimens were quite consistent. In 14 such paired determinations on individual
serum specimens the same titer was obtained in 10, and a difference of one dilution in 4.
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RESULTS
The diagnostic categories of the 369 patients whose serum was studied,
and qualitative results of the tests are indicated in Table 1. Positive tests
were obtained with all of 35 sera from patients with disseminated lupus
erythematosus. Positive results were also obtained with sera of 4 of 42
patients with rheumatoid arthritis, 1 of 3 with scleroderma, 1 of 2 with
dermatomyositis, 4 of 17 who had a chronic biologic false positive serologic
test for syphilis, and 1 of a
RESULTS OF 369 TESTS group with urticarial hyper-
NEGATIVE AT 1-2 DILUTION-319 sensitive reactions to drugs.
POSITIVE AT 1-2 OR HIGHER- 50 Of 5 patients with discoid
0 lupus without clinical or lab-
o oratory evidence of dissem-
0 a inated disease, none was posi-
o 0 U U_ tive.
*-LU
o o 0 a Amongall other seratested,
o * * * * * * 3 reacted with the nucleohis-
* * U * * U U tone. Two were in patients
* * * * * * * * considered to have late latent
I-a 1-4 l-x 1-16 I-32 -64 1-128 I-256 syphilis. Review of these pa-
TITER tients' records indicated that
there was no definite history
IPUS PATIENTS-3S O-OTHER PATIENTS-IS of syphilitic infection, and
FIG. 1. that the titer of activity in the
test for syphilis was low.
Treponema immobilization tests had not been done, but it is possible that
these represent biologic false positive reactions. The remaining serum
which reacted in the test with nucleohistone was a patient with far ad-
vanced metastatic bronchogenic carcinoma. There were no features sug-
gestive of lupus in this case.
Consideration of results of titration of the positive sera is essential for
full appraisal of results. These are shown in Figure 1. Reactions by sera
of patients not considered to have lupus, indicated by open squares in the
illustration, were of relatively low titer. There were two exceptions, both
of which were cases of particular interest. One was a young man with
findings consistent with rheumatoid arthritis of four years' duration. For
several months prior to the date of this test he had had intermittent slight
hematuria and albuminuria. On examination he was found to have gen-
eralized lymph node enlargement and splenomegaly in addition to evi-
dence of chronic joint disease compatible with rheumatoid arthritis.
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Shortly after the date of this test he developed an episode of pleurisy
on the right. L.E. tests at this time were negative. Recently he has suf-
fered a second episode of pleurisy, this time on the left side. At the pres-
ent time both the nucleohistone spot test and the L.E. test are positive.
The diagnosis of disseminated lupus erythematosus is clearly established
in this case. The second of these individuals was a middle-aged man with
scleroderma of several years' duration without evidence of recent activity.
He has had moderately severe thrombocytopenia and has also had inter-
mittent abnormal urinary findings. Because of these features the diagnosis
of disseminated lupus erythematosus was considered by many to be the
proper diagnosis in this case, although the final decision must await further
developments in the course of the disease. No other patients not previously
considered to have lupus had high titers, and none of those with low titers
had clinical features suggestive of disseminated lupus.
It has been indicated previously that many of the patients with lupus
were in a remission of variable degree, either sustained spontaneously, or
due to the suppressive action of prednisone. Detailed analysis of the
clinical course in relation to titer of affinity for nucleohistone will not be
described here. On the basis of the results of single tests, and a few individ-
uals from whom repeated serum specimens were obtained, certain general
statements can be made. It was evident that patients in remission of some
duration tended to have low titers. Patients who were acutely ill, or had
recently been so, had titers in the higher range. During the early weeks
of therapy with prednisone, however, improvement in the condition of the
patient was not necessarily accompanied by an abrupt fall in titer.
DISCUSSION
The data presented here indicate that measurement of this factor could
be usefully applied in diagnostic evaluation of patients with the rheumatic
diseases and related conditions. In this study the presence of the factor in
high titer has invariably been associated with findings consistent with the
diagnosis of disseminated lupus. It was not absent from the serum of any
established case.* In considering patients with clinical findings suggestive
of lupus, the finding of a high titer of this factor appears to be highly
* In data reported in connection with our study of the reaction of lupus sera with
intact nuclei, a single serum was obtained that failed to react.8 This specimen was from
an individual in a long sustained remission under prednisone therapy. The serum had
been stored in the refrigerator for 15 months before being received in this laboratory.
This specimen was not available when the present tests were being done, but a more
recent bleeding was positive at 1: 4 dilution. Although the factor is relatively stable, it
is felt that the activity of the first specimen may have been lost during the long
storage period.
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specific and the test useful as a means of establishing or eliminating dis-
seminated lupus erythematosus as a diagnostic possibility. The finding of
low titers in occasional patients with diseases closely akin to lupus re-
quires that any conclusions regarding specificity be qualified. These in-
dividuals did not have other manifestations of lupus, however, except for
a positive L.E. test in some instances. The complete natural history of
lupus is often long, and it is well known that in some instances an isolated
manifestation such as a chronic biologic false positive serologic test for
syphilis," or arthritis resembling rheumatoid arthritis,9 may precede the
complete clinical syndrome by long time intervals. The finding of low titer
of the factor in serum from some of these patients does not establish the
diagnosis of disseminated lupus in such a case. The observation is con-
sistent with prevalent concepts of the disease, however, and further study
of the occurrence of the factor in serum of patients not diagnosed as lupus
may provide information on the relationship between disseminated lupus
and these other conditions. The data suggest the interesting possibility
that detection of the factor at low level in rheumatoid arthritis, or in other
diseases, may be useful in anticipating future risk of occurrence of dis-
seminated lupus.
It is attractive to reflect on the possibility that the factor may be impli-
cated in the pathogenesis of this disease, especially in view of the recent
emphasis on altered nuclear material among the histopathologic findings
in lupus.i Evidence available at present does not indicate whether we are
dealing with a cause or a result. The concept of lupus as a disease due to
"auto-antibodies" has been popular in recent years. The factor under
study is part of the gamma globulin fraction of serum proteins, and its
properties are compatible with those of a heterogenetic antibody. Rob-
bins, et al., have recently reported complement fixation when sera from
some patients with lupus are exposed to intact nuclei or DNA.1" This ob-
servation provides additional support for such a concept. However, sera
from a considerable proportion of such patients did not possess such com-
plement-fixing activity. The full significance of these observations remains
to be determined.
The connection between this factor and that responsible for the L.E.
phenomenon is of considerable interest. In an early study Miescher re-
ported that when serum of patients with lupus was incubated with nuclei,
the ability to induce L.E. cells was eliminated.1" With application of the
fluorescent antibody technique to this problem it was possible to demon-
strate more directly that under such conditions globulin is bound to nuclei.8
In another report the procedure applied here was described and it
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was demonstrated that absorption of lupus serum with nucleoprotein re-
moves L.E. phenomenon activity and this factor simultaneously.! Presum-
ably the factor detected by the method used here is the L.E. factor, and
its reaction with nucleoprotein is the first step in the L.E. phenomenon.
In data presented elsewhere it was demonstrated that all of these sera
reacted with nucleoprotein spots although many failed to induce a positive
L.E. test. The data indicated that among sera positive with the nucleo-
protein spot test there was no clear relationship between titer of this factor
and ability of a particular serum to induce L.E. cells.5 A possible explana-
tion for this finding may be found in recent observations of Finch and
Detre,3 who demonstrated that serum of most patients with disseminated
lupus has a depressing effect on phagocytosis. Such an effect would tend
to obscure any relationship that might exist between titer of a serum factor
and induction of L.E. cells.
Experience with the fluorescent antibody technique until quite recently
would indicate limited applicability as a generally used diagnostic test.
There have recently been improvements in available standard optical sys-
tems for fluorescence microscopy. Methods of labelling of antisera with
fluorescent dyes have also been simplified.' Furthermore, experience in
this laboratory has indicated that fluorescence of spots of nucleoprotein
may be determined by gross inspection with an inexpensive source of ultra-
violet light. Other methods of detecting the reaction have also been in-
vestigated. A technique using iodine131 instead of the fluorescent dye as
a label on anti-human globulin has recently been reported. Experience
with a modification of the latter procedure indicates that it is an accurate
and sensitive means of measuring the factor in human serum.6&
SUMMARY
Sera from patients with a variety of human diseases have been tested
for presence of a globulin factor which reacts with nucleoprotein. The tests
were made, and activity of the factor titrated, with an adaptation of the
fluorescent antibody technique. The factor was found to be characteristic
of sera of patients with disseminated lupus erythematosis, especially when
present in high titer. It was also present in low titer in occasional sera
of patients with disease syndromes known to be closely related to lupus,
especially rheumatoid arthritis and individuals with chronic biologic false
positive serologic tests for syphilis. The possible significance of these
findings is discussed, and use of this procedure as a diagnostic method
considered.
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